Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Nowfar
REPLACE-CV, NCT05605964: Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate	Active, not recruiting	3	2250	US	Relugolix, ORGOVYX, TAK-385, MVT-601, RVT-601, T-1331285, Leuprolide Acetate, Leuprolide	Sumitomo Pharma Switzerland GmbH	Prostate Cancer	12/24	12/24